Similarly, CCL3 has been reported to be higher in the liver and serum of patients with biopsy-proven NASH compared to patients with simple hepatic steatosis or controls [142, 144, 151, 152]. This evidence concerns the gene CCL3 and metabolic dysfunction-associated steatohepatitis.